Medicine guide
GAVRETO
As listed in the register: GAVRETO 100 mg, gélule
100 mg · gélule
- Prescription only
- Active substance
- Pralsétinib
- Made by
- BLUEPRINT MEDICINES (PAYS-BAS))
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | BLUEPRINT MEDICINES (PAYS-BAS)) |
|---|---|
| Active substance | Pralsétinib |
| Strength | 100 mg |
| Form | gélule |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE |
| Marketed | No — authorised but not currently marketed, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/21/1555 |
| Name in the register | GAVRETO 100 mg, gélule |
| Packs | 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 gélule(s) |
| CIS | 67194402 |
| CIP13 | 3400930241448 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).